MeSH tree: E05.200.500
A research team has developed a combination immunotherapy that uses an electrical ablation technique to enhance the efficacy of immune cell therapy against liver cancer.
8 hours ago
0
1
By analyzing heart rhythm recordings and blood tests, artificial intelligence may accurately flag when a transplant patient's body starts attacking a donated heart, a new study suggests.
Oct 6, 2026
0
5
Understanding how fetal DNA travels in a pregnant woman's blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances.
Oct 2, 2026
0
10
A real-world study of 8,391 patients found that autonomous artificial intelligence (AI) could free up enough clinical capacity to provide more than 8,500 additional face-to-face dermatology appointments across two U.K. hospitals ...
Sep 30, 2026
0
8
Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas. Nonmelanoma skin cancers—primarily ...
Sep 30, 2026
0
8
Low-dose aspirin was associated with a 70% lower risk of dementia among older people with a particular genetic profile, a new Monash University analysis has found, raising the possibility of a more personalized approach to ...
Sep 29, 2026
0
130
In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.
Sep 29, 2026
0
13
A test that compares the levels of two molecules in the blood can accurately distinguish between bacterial and viral infections in newborn babies with fever, according to a small study presented at the European Emergency ...
Sep 26, 2026
0
10
As more individuals with cerebral palsy live well into adulthood, medical professionals are taking a closer look at the unique long-term health care needs of this patient population. While adults with cerebral palsy require ...
Sep 9, 2026
0
6
Immune cells that are engineered to attack cancer cells, known as CAR-T cells, are used to treat some types of blood cancer. However, only about 5% of hospitals in the United States can generate and deliver CAR-T cells to ...
Aug 19, 2026
0
9
